Saving your money for next purchases
Daratumumab Injection 达妥昔单抗注射液
Datuximab beta injection, also known as Kaiserb, is indicated for the treatment of high-risk neuroblastoma patients aged 12 months and above, and patients with relapsed or refractory neuroblastoma with or without residual lesions. The drug is the first targeted immunotherapy drug approved by the China National Medical Products Administration (NMPA) for the treatment of neuroblastoma.
Share:
Products
Our offers
Delivery – when you want and anywhere
A huge selection of best products
Health Classification
Let us work together to protect precious health
